Metformin in COVID-19: A possible role beyond diabetes.
作者信息
Sharma Swati, Ray Avik, Sadasivam Balakrishnan
机构信息
Department of Pharmacology, All India Institute of Medical Sciences Bhopal, Madhya Pradesh, India.
Department of Pharmacology, All India Institute of Medical Sciences Bhopal, Madhya Pradesh, India.
出版信息
Diabetes Res Clin Pract. 2020 Jun;164:108183. doi: 10.1016/j.diabres.2020.108183. Epub 2020 Apr 30.
Abstract
摘要
相似文献
1
Metformin in COVID-19: A possible role beyond diabetes.二甲双胍在新冠病毒疾病中的作用：可能超越糖尿病范畴。
Diabetes Res Clin Pract. 2020 Jun;164:108183. doi: 10.1016/j.diabres.2020.108183. Epub 2020 Apr 30.
2
Diabetes and coronavirus (SARS-CoV-2): Molecular mechanism of Metformin intervention and the scientific basis of drug repurposing.糖尿病与冠状病毒（SARS-CoV-2）：二甲双胍干预的分子机制与药物再利用的科学基础。
PLoS Pathog. 2021 Jun 22;17(6):e1009634. doi: 10.1371/journal.ppat.1009634. eCollection 2021 Jun.
3
Repurposing metformin for covid-19 complications in patients with type 2 diabetes and insulin resistance.将二甲双胍重新用于 2 型糖尿病伴胰岛素抵抗患者的新冠病毒并发症。
Immunopharmacol Immunotoxicol. 2021 Jun;43(3):265-270. doi: 10.1080/08923973.2021.1925294. Epub 2021 May 31.
4
Therapeutic Potential of Metformin in COVID-19: Reasoning for Its Protective Role.二甲双胍在 COVID-19 中的治疗潜力：其保护作用的推理。
Trends Microbiol. 2021 Oct;29(10):894-907. doi: 10.1016/j.tim.2021.03.004. Epub 2021 Mar 14.
5
Metformin as a potential treatment for COVID-19.二甲双胍作为治疗 COVID-19 的一种潜在药物。
Expert Opin Pharmacother. 2023 May-Aug;24(10):1199-1203. doi: 10.1080/14656566.2023.2215385. Epub 2023 May 18.
6
[Continuing or stopping metformin in patients with type 2 diabetes exposed to SARS-CoV-2 ?].2型糖尿病患者感染新型冠状病毒后二甲双胍应继续使用还是停用？
Rev Med Liege. 2021 Mar;76(3):152-155.
7
Metformin in SARS-CoV-2 infection: A hidden path - from altered inflammation to reduced mortality. A review from the literature.二甲双胍在 SARS-CoV-2 感染中的作用：一条被忽视的通路——从改变炎症反应到降低死亡率。文献综述。
J Diabetes Complications. 2023 Feb;37(2):108391. doi: 10.1016/j.jdiacomp.2022.108391. Epub 2023 Jan 2.
8
Investigating the impact of metformin on severity of COVID-19 in patients with Type 2 diabetes mellitus: Focusing on laboratory findings.探讨二甲双胍对 2 型糖尿病患者 COVID-19 严重程度的影响：重点关注实验室发现。
Endocrinol Diabetes Metab. 2023 Sep;6(5):e441. doi: 10.1002/edm2.441. Epub 2023 Jul 11.
9
Effects of Metformin, Insulin on Hematological Parameters of COVID-19 Patients with Type 2 Diabetes.二甲双胍、胰岛素对 2 型糖尿病 COVID-19 患者血液学参数的影响。
Med Arch. 2022 Oct;76(5):329-332. doi: 10.5455/medarh.2022.76.329-332.
10
Metformin suppresses SARS-CoV-2 in cell culture.二甲双胍在细胞培养中可抑制新型冠状病毒。
Virus Res. 2023 Jan 2;323:199010. doi: 10.1016/j.virusres.2022.199010. Epub 2022 Nov 20.
引用本文的文献
1
Metformin for covid-19: systematic review and meta-analysis of randomised controlled trials.二甲双胍用于治疗新冠肺炎：随机对照试验的系统评价与荟萃分析
BMJ Med. 2025 May 21;4(1):e001126. doi: 10.1136/bmjmed-2024-001126. eCollection 2025.
2
Autophagy and Respiratory Viruses: Mechanisms, Viral Exploitation, and Therapeutic Insights.自噬与呼吸道病毒：机制、病毒利用及治疗见解
Cells. 2025 Mar 12;14(6):418. doi: 10.3390/cells14060418.
3
Does the Consumption of Metformin Correlate With a Reduction in Mortality Among Patients With Type 2 Diabetes and COVID-19 in Morocco?在摩洛哥，2型糖尿病合并新冠肺炎患者服用二甲双胍与死亡率降低有关联吗？
Cureus. 2025 Jan 11;17(1):e77288. doi: 10.7759/cureus.77288. eCollection 2025 Jan.
4
Herbal Medicines as Complementary Therapy for Managing Complications in COVID-19 Patients with Diabetes Mellitus.草药作为管理2型糖尿病合并新冠患者并发症的辅助疗法
Diabetes Metab Syndr Obes. 2025 Jan 16;18:135-146. doi: 10.2147/DMSO.S498774. eCollection 2025.
5
Emerging small-molecule antiviral agents in long COVID prevention.用于预防新冠后遗症的新型小分子抗病毒药物
Front Pharmacol. 2024 Oct 9;15:1457672. doi: 10.3389/fphar.2024.1457672. eCollection 2024.
6
Prevalence, Predictors, and Outcomes of Type 2 NSTEMI in Hospitalized Patients With COVID-19.COVID-19 住院患者 2 型 NSTEMI 的患病率、预测因素和结局。
J Am Heart Assoc. 2024 May 21;13(10):e032572. doi: 10.1161/JAHA.123.032572. Epub 2024 May 10.
7
The Effect of Antihyperglycemic Medications on COVID-19: A Meta-analysis and Systematic Review from Observational Studies.抗高血糖药物对 COVID-19 的影响：来自观察性研究的荟萃分析和系统评价。
Ther Innov Regul Sci. 2024 Jul;58(4):773-787. doi: 10.1007/s43441-024-00633-6. Epub 2024 Apr 29.
8
Type 1 Diabetes and COVID-19: A Literature Review and Possible Management.1型糖尿病与2019冠状病毒病：文献综述及可能的管理方法
Int J Endocrinol Metab. 2023 Oct 23;21(4):e139768. doi: 10.5812/ijem-139768. eCollection 2023 Oct.
9
Is Metformin Use Associated with a More Favorable COVID-19 Course in People with Diabetes?二甲双胍的使用是否与糖尿病患者更有利的COVID-19病程相关？
J Clin Med. 2024 Mar 24;13(7):1874. doi: 10.3390/jcm13071874.
10
Unveiling the potential pleiotropic effects of metformin in treating COVID-19: a comprehensive review.揭示二甲双胍治疗新冠肺炎的潜在多效性：一项综述
Front Mol Biosci. 2023 Oct 10;10:1260633. doi: 10.3389/fmolb.2023.1260633. eCollection 2023.
本文引用的文献
1
Inhaled biguanides and mTOR inhibition for influenza and coronavirus (Review).吸入性双胍类药物与mTOR抑制用于流感和冠状病毒（综述）
World Acad Sci J. 2020 May;2(3). doi: 10.3892/wasj.2020.42. Epub 2020 Mar 29.
2
COVID-19 and diabetes management: What should be considered?2019冠状病毒病与糖尿病管理：应考虑哪些方面？
Diabetes Res Clin Pract. 2020 May;163:108151. doi: 10.1016/j.diabres.2020.108151. Epub 2020 Apr 17.
3
Should anti-diabetic medications be reconsidered amid COVID-19 pandemic?在新冠疫情期间是否应重新考虑抗糖尿病药物？
Diabetes Res Clin Pract. 2020 May;163:108146. doi: 10.1016/j.diabres.2020.108146. Epub 2020 Apr 10.
4
COVID-19 and diabetes: Knowledge in progress.新型冠状病毒肺炎与糖尿病：知识在不断更新。
Diabetes Res Clin Pract. 2020 Apr;162:108142. doi: 10.1016/j.diabres.2020.108142. Epub 2020 Apr 9.
5
Angiotensin-Converting Enzyme 2: SARS-CoV-2 Receptor and Regulator of the Renin-Angiotensin System: Celebrating the 20th Anniversary of the Discovery of ACE2.血管紧张素转换酶 2：SARS-CoV-2 受体和肾素-血管紧张素系统的调节剂：庆祝 ACE2 发现 20 周年。
Circ Res. 2020 May 8;126(10):1456-1474. doi: 10.1161/CIRCRESAHA.120.317015. Epub 2020 Apr 8.
6
Angiotensin Converting Enzyme 2: A Double-Edged Sword.血管紧张素转换酶2：一把双刃剑。
Circulation. 2020 Aug 4;142(5):426-428. doi: 10.1161/CIRCULATIONAHA.120.047049. Epub 2020 Mar 26.
7
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor.严重急性呼吸综合征冠状病毒 2 型（SARS-CoV-2）进入细胞依赖于 ACE2 和 TMPRSS2，可被一种临床验证的蛋白酶抑制剂所阻断。
Cell. 2020 Apr 16;181(2):271-280.e8. doi: 10.1016/j.cell.2020.02.052. Epub 2020 Mar 5.
8
AMP-Activated Protein Kinase Restricts Zika Virus Replication in Endothelial Cells by Potentiating Innate Antiviral Responses and Inhibiting Glycolysis.AMP 激活的蛋白激酶通过增强先天抗病毒反应和抑制糖酵解来限制内皮细胞中的寨卡病毒复制。
J Immunol. 2020 Apr 1;204(7):1810-1824. doi: 10.4049/jimmunol.1901310. Epub 2020 Feb 21.
9
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.中国武汉地区 2019 年新型冠状病毒感染患者的临床特征。
Lancet. 2020 Feb 15;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5. Epub 2020 Jan 24.
10
AMPK: a balancer of the renin-angiotensin system.AMPK：肾素-血管紧张素系统的平衡器。
Biosci Rep. 2019 Sep 3;39(9). doi: 10.1042/BSR20181994. Print 2019 Sep 30.
Zotero 插件